Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra M Herrmann

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Stem Cell Research & Therapy|April 15, 2021
Hypoxic preconditioning induces epigenetic changes and modifies swine mesenchymal stem cell angiogenesis and senescence in experimental atherosclerotic renal artery stenosisBusra Isik, Roman Thaler, Busra B Goksu, et al.
Journal for Immunotherapy of Cancer|January 19, 2023
Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritisMeghan E Sise, Qiyu Wang, Harish Seethapathy, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 2, 2012
Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseasesNelson Leung, Morie Gertz, Robert A Kyle, et al.
BMJ Open Diabetes Research & Care|January 8, 2020
Senescence marker activin A is increased in human diabetic kidney disease: association with kidney function and potential implications for therapyXiaohui Bian, Tomás P Griffin, Xiangyang Zhu, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 7, 2024
Assessment of GFR in Patients with Cancer: A Statement from the American Society of Onco-NephrologyAbhijat Kitchlu, Verônica T Costa E Silva, Shuchi Anand, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 24, 2024
Assessment of GFR in Patients with Cancer Part 2: Anticancer Therapies-Perspectives from the American Society of Onco-Nephrology (ASON)Abhijat Kitchlu, Verônica T Costa E Silva, Shuchi Anand, et al.
Diabetes|April 16, 2021
Diabetic Kidney Disease Alters the Transcriptome and Function of Human Adipose-Derived Mesenchymal Stromal Cells but Maintains Immunomodulatory and Paracrine Activities Important for Renal RepairLaTonya J Hickson, Alfonso Eirin, Sabena M Conley, et al.
Journal of the American Society of Nephrology : JASN|January 4, 2020
Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter StudyFrank B Cortazar, Zoe A Kibbelaar, Ilya G Glezerman, et al.
Journal for Immunotherapy of Cancer|September 22, 2022
Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKIShruti Gupta, Clara Garcia-Carro, Jason M Prosek, et al.
Kidney International|August 14, 2022
Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancerShruti Gupta, Ian A Strohbehn, Qiyu Wang, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Stem Cell Research & Therapy|April 15, 2021
Hypoxic preconditioning induces epigenetic changes and modifies swine mesenchymal stem cell angiogenesis and senescence in experimental atherosclerotic renal artery stenosisBusra Isik, Roman Thaler, Busra B Goksu, et al.
Journal for Immunotherapy of Cancer|January 19, 2023
Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritisMeghan E Sise, Qiyu Wang, Harish Seethapathy, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 2, 2012
Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseasesNelson Leung, Morie Gertz, Robert A Kyle, et al.
BMJ Open Diabetes Research & Care|January 8, 2020
Senescence marker activin A is increased in human diabetic kidney disease: association with kidney function and potential implications for therapyXiaohui Bian, Tomás P Griffin, Xiangyang Zhu, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 7, 2024
Assessment of GFR in Patients with Cancer: A Statement from the American Society of Onco-NephrologyAbhijat Kitchlu, Verônica T Costa E Silva, Shuchi Anand, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 24, 2024
Assessment of GFR in Patients with Cancer Part 2: Anticancer Therapies-Perspectives from the American Society of Onco-Nephrology (ASON)Abhijat Kitchlu, Verônica T Costa E Silva, Shuchi Anand, et al.
Diabetes|April 16, 2021
Diabetic Kidney Disease Alters the Transcriptome and Function of Human Adipose-Derived Mesenchymal Stromal Cells but Maintains Immunomodulatory and Paracrine Activities Important for Renal RepairLaTonya J Hickson, Alfonso Eirin, Sabena M Conley, et al.
Journal of the American Society of Nephrology : JASN|January 4, 2020
Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter StudyFrank B Cortazar, Zoe A Kibbelaar, Ilya G Glezerman, et al.
Journal for Immunotherapy of Cancer|September 22, 2022
Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKIShruti Gupta, Clara Garcia-Carro, Jason M Prosek, et al.
Kidney International|August 14, 2022
Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancerShruti Gupta, Ian A Strohbehn, Qiyu Wang, et al.
Pageof 10